期刊文献+

超声联合血清MYCN、Smad7 mRNA检测对神经母细胞瘤的诊断价值 被引量:2

Diagnostic value of ultrasound combined with serum MYCN and Smad7 mRNA detection in neuroblastoma
下载PDF
导出
摘要 目的:探讨彩色多普勒超声联合血清MYCN、Smad7 mRNA检测在诊断儿童神经母细胞瘤中的临床价值。方法:选取确诊的48例神经母细胞瘤患儿为神经母细胞瘤组,同期选取因腹胀、腹泻、便秘、呕吐等原因就诊最终排除神经母细胞瘤的患儿50例作为对照组,对其均行彩色多普勒超声检查。采用实时荧光定量PCR(qRT-PCR)法检测血清MYCN mRNA、Smad7 mRNA表达水平。绘制受试者工作特征(ROC)曲线分析血清MYCN mRNA、Smad7 mRNA对神经母细胞瘤的诊断效能,采用一致性Kappa检验分析各诊断方法与手术或穿刺病理结果的一致性。结果:神经母细胞瘤组血清MYCN mRNA、Smad7 mRNA表达水平显著高于对照组(均P<0.05)。血清MYCN mRNA、Smad7 mRNA诊断神经母细胞瘤的曲线下面积(AUC)分别为0.867(95%CI:0.795~0.938)、0.818(95%CI:0.734~0.901),特异度分别为88.00%、84.00%,灵敏度均为75.00%。超声检查结果中假阳性8例,假阴性11例,与手术或穿刺病理结果的一致性较高,Kappa值为0.612(P<0.05);超声联合血清MYCN mRNA、Smad7 mRNA检查结果中假阳性9例,假阴性4例,与手术或穿刺病理结果的一致性较高,Kappa值为0.735(P<0.05)。超声联合血清MYCN mRNA、Smad7 mRNA诊断神经母细胞瘤的灵敏度显著高于三者单独诊断(P<0.05)。结论:超声检查对儿童神经母细胞瘤有较高的诊断价值,其联合血清MYCN mRNA、Smad7 mRNA后诊断价值有一定的提高。 Objective:To investigate the clinical value of color Doppler ultrasonography combined with serum MYCN and Smad7 mRNA detection in the diagnosis of neuroblastoma in children.Methods:A total of 48 children with neuroblastoma were taken as the neuroblastoma group.Meantime,50 children who were excluded from neuroblastoma after caming to the hospital for abdominal distension,diarrhea,constipation,vomiting and other reasons were selected as the control group.All of them underwent color Doppler ultrasonography.Quantitative real-time PCR(qRT-PCR)was applied to detect the levels of serum MYCN mRNA and Smad7 mRNA.ROC curve was drawn to analyze the diagnostic efficacy of serum MYCN mRNA and Smad7 mRNA for neuroblastoma.Concordance Kappa test was applied to analyze the consistency of each diagnostic method with surgical or puncture pathological results.Results:Serum levels of MYCN mRNA and Smad7 mRNA in neuroblastoma group were obviously higher than those in control group(all P<0.05).The AUC of serum MYCN mRNA and Smad7 mRNA in the diagnosis of neuroblastoma was 0.867(95%CI:0.795 to 0.938)and 0.818(95%CI:0.734 to 0.901),respectively,and the specificity was 88.00%and 84.00%,respectively,both had a sensitivity of 75.00%.There were 8 false positives and 11 false negatives in the ultrasonography results,which were highly consistent with the surgical or puncture pathological results,with a Kappa value of 0.612(P<0.05).Ultrasound combined with serum MYCN mRNA and Smad7 mRNA test results showed 9 false positives and 4 false negatives,which were highly consistent with the results of surgery or biopsy,with a Kappa value of 0.735(P<0.05).The sensitivity of ultrasound combined with serum MYCN mRNA and Smad7 mRNA in the diagnosis of neuroblastoma was obviously higher than that of the three alone(all P<0.05).Conclusion:Ultrasound examination has a high diagnostic value for childhood neuroblastoma,and its diagnostic value can be improved to a certain extent when combined with serum MYCN mRNA and Smad7 mRNA.
作者 张明 蒋兰君 左汴京 霍亚玲 ZHANG Ming;JIANG Lanjun;ZUO Bianjing;HUO Yaling(Children’s Hospital Affiliate to Zhengzhou University,Zhengzhou 450018,China)
出处 《陕西医学杂志》 CAS 2022年第11期1441-1444,共4页 Shaanxi Medical Journal
关键词 神经母细胞瘤 诊断 病理检查 超声检查 MYCN基因 SMAD7基因 Neuroblastoma Diagnosis Pathological examination Ultrasonography MYCN gene Smad7 gene
  • 相关文献

参考文献8

二级参考文献96

  • 1陈腾,赵新汉,杨广夫.腹膜后神经节母细胞瘤1例报告[J].实用放射学杂志,1997,13(1):53-54. 被引量:2
  • 2张卫星,黄耀,邓卫萍.高强度聚焦超声治疗中晚期肝癌后早期肝功能变化观察[J].临床和实验医学杂志,2007,6(7):25-26. 被引量:1
  • 3石木兰 韦嘉瑚.肿瘤影像诊断学[M].合肥:安徽科学技术出版社,1995.257.
  • 4吴瑞萍 胡亚美 等.实用儿科学(下册)第6版[M].北京:人民卫生出版社,1996.2233-2236.
  • 5李果珍 戴建平.临床全身CT诊断学[M].北京:中国科学技术出版社,1994.505-506.
  • 6Howlader N, Noone AM, Krapcho M, et al, eds. SEER statistics review, 1975-2009 ( Vintage 2009 Populations)[M]. Bethesda, Md: National Cancer Institute, 2012.
  • 7Homer M J, Ries LA, Krapcho M, et al. SEER cancer statistics review, 1975-2006[M]. Bethesda, Md: National Cancer Institute, 2009.
  • 8Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, andresponse to treatment[J]. J Clin Oncol, 1993, 11 (8): 1466- 1477.
  • 9Shimada H,Ambros IM, Dehner LP, et al. The Ivtemational Neuroblastoma Pathology Classification (the Shimada system) [J]. Cancer,1999,86 (2) : 364-372.
  • 10Peuchmaur M Amore ES, Joshi VV, et al. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular [J ]. Cancer, 2003, 98 (10) : 2274-2281.

共引文献135

同被引文献19

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部